MktsMarkets

Health Catalyst, Inc
NASDAQ: HCATKey statistics
HCAT News
Stories mentioning HCAT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 70,756 | 74,679 | 76,323 | 80,721 | 79,413 | 79,606 | 76,353 | 75,902 |
| Cost of Goods Sold | ||||||||
| Gross Profit | 40,133 | 36,289 | ||||||
| Operating Expenses | ||||||||
| Research & Development | 9,779 | 9,911 | 12,281 | 12,392 | 15,186 | 15,002 | 14,193 | 13,884 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 141,940 | 125,463 | 55,325 | 75,335 | 56,406 | 52,191 | 47,727 | 51,649 |
| Operating Income (Loss) | (106,477) | (86,080) | (17,509) | (37,094) | (20,171) | (17,500) | (13,687) | (15,807) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 414.00 | 379.00 | 41.00 | 81.00 | 215.00 | 625.00 | (475.00) | 70.00 |
| Net Income (Loss) | (111,026) | (91,025) | (22,229) | (40,978) | (23,742) | (20,673) | (14,726) | (13,516) |
| Earnings Per Share (Basic) | (1.53) | (1.30) | (0.32) | (0.59) | (0.35) | (0.34) | (0.24) | (0.23) |
| Earnings Per Share (Diluted) | (1.53) | (1.30) | (0.32) | (0.59) | (0.35) | (0.34) | (0.24) | (0.23) |
| Weighted Average Shares Outstanding (Basic) | 72,593 | 69,896 | 70,377 | 69,626 | 68,552 | 60,185 | 60,441 | 59,304 |
| Weighted Average Shares Outstanding (Diluted) | 72,593 | 69,896 | 70,377 | 69,626 | 68,552 | 60,185 | 60,441 | 59,304 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About HCAT
Health Catalyst, Inc (NASDAQ: HCAT) is a stock listed on the Nasdaq Stock Market under the ticker symbol HCAT. It last traded at $1.58 (Nov 2, 2026, 4:00 PM ET), down 6.5% on the day. That gives Health Catalyst a market capitalisation of $121.5M.
Over the past 52 weeks HCAT has traded between $0.9500 and $3.37.
Revenue for the quarter ended Mar 31, 2026 was $70.8M; a net loss of $111.0M. Revenue was down 10.9% from $79.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $70.8M | -$111.0M | -156.9% |
| Dec 31, 2025 | $74.7M | -$91.0M | -121.9% |
| Sep 30, 2025 | $76.3M | -$22.2M | -29.1% |
| Jun 30, 2025 | $80.7M | -$41.0M | -50.8% |
From Health Catalyst’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…